BRAND_ANALYSIS#JOHNSON_AND_JOHNSONHEALTH & PHARMA#4 OF 26 IN HEALTH & PHARMAINTERESTING
Johnson & Johnson
· Public · Updated 23 Aug 2026 07:27 UTC
#97 of 1208 overall by tension · #4 of 26 in Health & Pharma
27Interesting
The Silent Giant
Analysis
J&J's C=55/B=82 and 0.50 sentiment describe a healthcare giant that has quietly stabilized after years of talc litigation headlines. The 4.23% stock gain is unremarkable but steady — this is a brand built for institutional trust, not cultural heat.
IN THE NEWS (100 articles this week)
Johnson & Johnson Publishes New Future of Digital Surgery Report to Help Define the Emerging Field of Surgical Intelligence - Johnson & Johnson
Johnson & Johnson | History, Products, & Controversies - Encyclopedia Britannica
Johnson & Johnson names new vice president for litigation - Reuters